CIDSTEM has a GMP-authorized facility for the implementation of advanced therapies and the technical and professional skills to manage the GMP laboratory and clinical trials of these therapies.
It therefore possesses the know-how and instrumentation necessary to offer companies:
-an implementation service for research and clinical trials, approved by regulatory bodies, of advanced therapies involving cell cultures in GMP;
-A consulting service for the technological transfer of clinical and preclinical trials in GMP and for the production of cell cultures for advanced therapies.
-An implementation service of research aimed at the industrialization of cell cultures for the development of ATMPs;
-a testing service of new technologies (nanomaterials, scaffolds for the realization of 3D cellular tissues, laboratory equipment, software for clinical trials and for the management of biological data, GMP compliant logistics, etc.).
Translated with www.DeepL.com/Translator (free version)